data_2ajo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ajo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.08 0.467 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.89 77.91 0.97 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.58 41.27 32.12 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.779 -0.836 . . . . 0.0 110.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 35.8 t80 -113.04 165.73 12.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.365 -0.835 . . . . 0.0 110.474 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 14.3 t 72.77 -10.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.975 -0.453 . . . . 0.0 111.633 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.17 -47.32 4.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.094 -1.004 . . . . 0.0 109.514 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.15 -34.68 78.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.841 -0.537 . . . . 0.0 110.327 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.22 -40.25 95.65 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.416 -0.803 . . . . 0.0 110.09 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mm -68.19 -34.42 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.56 -0.712 . . . . 0.0 109.859 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -73.59 -24.52 60.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -55.35 -35.56 65.35 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 tp -80.91 -32.82 34.57 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -54.58 -44.08 72.69 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.919 -0.488 . . . . 0.0 110.658 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -38.29 83.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -37.97 78.46 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.686 -0.634 . . . . 0.0 109.758 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mt -74.74 -39.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 109.615 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -66.83 -48.67 68.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.679 -0.638 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -30.17 61.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.474 -0.767 . . . . 0.0 110.358 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.31 91.21 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.16 51.03 1.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.445 -1.032 . . . . 0.0 109.695 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.24 -55.66 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 109.982 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -70.42 -33.77 71.73 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.309 -0.869 . . . . 0.0 110.552 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG13 ' HG3' ' A' ' 22' ' ' LYS . 59.1 mt -90.93 -37.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.359 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -72.0 -48.15 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.565 -0.709 . . . . 0.0 110.165 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.77 6.24 39.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.415 -0.803 . . . . 0.0 110.883 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -7.69 44.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -124.84 57.63 1.27 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.042 -1.269 . . . . 0.0 110.285 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.395 179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.08 0.467 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.89 77.91 0.97 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.58 41.27 32.12 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.779 -0.836 . . . . 0.0 110.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 35.8 t80 -113.04 165.73 12.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.365 -0.835 . . . . 0.0 110.474 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 14.3 t 72.77 -10.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.975 -0.453 . . . . 0.0 111.633 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.17 -47.32 4.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.094 -1.004 . . . . 0.0 109.514 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.15 -34.68 78.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.841 -0.537 . . . . 0.0 110.327 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 8' ' ' LEU . 3.3 mm? -64.22 -40.25 95.65 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.416 -0.803 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mm -68.19 -34.42 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.56 -0.712 . . . . 0.0 109.859 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -73.59 -24.52 60.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -55.35 -35.56 65.35 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 tp -80.91 -32.82 34.57 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -54.58 -44.08 72.69 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.919 -0.488 . . . . 0.0 110.658 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -38.29 83.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -37.97 78.46 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.686 -0.634 . . . . 0.0 109.758 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mt -74.74 -39.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 109.615 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -66.83 -48.67 68.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.679 -0.638 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -30.17 61.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.474 -0.767 . . . . 0.0 110.358 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.31 91.21 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.16 51.03 1.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.445 -1.032 . . . . 0.0 109.695 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.24 -55.66 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 109.982 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HG3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -70.42 -33.77 71.73 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.309 -0.869 . . . . 0.0 110.552 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 22' ' ' LYS . 59.1 mt -90.93 -37.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.359 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -72.0 -48.15 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.565 -0.709 . . . . 0.0 110.165 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.77 6.24 39.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.415 -0.803 . . . . 0.0 110.883 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -7.69 44.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -124.84 57.63 1.27 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.042 -1.269 . . . . 0.0 110.285 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.395 179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.08 0.467 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.89 77.91 0.97 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.58 41.27 32.12 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.779 -0.836 . . . . 0.0 110.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 35.8 t80 -113.04 165.73 12.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.365 -0.835 . . . . 0.0 110.474 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 14.3 t 72.77 -10.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.975 -0.453 . . . . 0.0 111.633 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.17 -47.32 4.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.094 -1.004 . . . . 0.0 109.514 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.15 -34.68 78.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.841 -0.537 . . . . 0.0 110.327 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 8' ' ' LEU . 3.3 mm? -64.22 -40.25 95.65 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.416 -0.803 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mm -68.19 -34.42 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.56 -0.712 . . . . 0.0 109.859 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -73.59 -24.52 60.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -55.35 -35.56 65.35 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 tp -80.91 -32.82 34.57 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -54.58 -44.08 72.69 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.919 -0.488 . . . . 0.0 110.658 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -38.29 83.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -37.97 78.46 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.686 -0.634 . . . . 0.0 109.758 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 mt -74.74 -39.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.444 -0.785 . . . . 0.0 109.615 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -66.83 -48.67 68.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.679 -0.638 . . . . 0.0 110.512 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -30.17 61.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.474 -0.767 . . . . 0.0 110.358 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.31 91.21 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.16 51.03 1.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.445 -1.032 . . . . 0.0 109.695 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.24 -55.66 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 109.982 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HG3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -70.42 -33.77 71.73 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.309 -0.869 . . . . 0.0 110.552 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 22' ' ' LYS . 59.1 mt -90.93 -37.59 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.359 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.3 t -72.0 -48.15 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.565 -0.709 . . . . 0.0 110.165 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.77 6.24 39.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.415 -0.803 . . . . 0.0 110.883 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -7.69 44.96 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -124.84 57.63 1.27 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.042 -1.269 . . . . 0.0 110.285 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.395 179.878 . . . . . . . . 0 0 . 1 stop_ save_